Eloxx Pharmaceuticals, Inc. SEC filings ELOX
Eloxx Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Dec 23, 2008. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 22, 2026 | — |
| S-1 | Registration statement | Sep 11, 2026 | — |
| 424B4 | Prospectus | Jun 9, 2026 | — |
| S-1/A | Amended registration statement | Jun 4, 2026 | — |
| S-1/A | Amended registration statement | Jun 1, 2026 | — |
| S-1 | Registration statement | May 7, 2026 | — |
| S-3 | Shelf registration | Jan 25, 2024 | — |
| S-8 | Employee stock plan registration | Jan 24, 2024 | — |
| 424B5 | Prospectus supplement | Sep 20, 2023 | — |
| 424B5 | Prospectus supplement | Aug 11, 2023 | — |
| 424B5 | Prospectus supplement | May 24, 2023 | — |
| S-8 | Employee stock plan registration | Mar 31, 2023 | — |
| 424B5 | Prospectus supplement | May 6, 2022 | — |
| 424B5 | Prospectus supplement | Sep 30, 2021 | — |
| S-3 | Shelf registration | Aug 20, 2021 | — |
| 424B5 | Prospectus supplement | May 17, 2021 | — |
| 424B5 | Prospectus supplement | May 13, 2021 | — |
| S-8 | Employee stock plan registration | Mar 12, 2021 | — |
| S-8 | Employee stock plan registration | Mar 6, 2020 | — |
| 424B5 | Prospectus supplement | Jun 20, 2019 | — |
| 424B5 | Prospectus supplement | Jun 19, 2019 | — |
| S-3 | Shelf registration | Nov 16, 2018 | — |
| 424B5 | Prospectus supplement | Nov 16, 2018 | — |
| S-8 | Employee stock plan registration | May 11, 2018 | — |
| 424B5 | Prospectus supplement | Apr 26, 2018 | — |
| 424B5 | Prospectus supplement | Apr 24, 2018 | — |
| S-3 | Shelf registration | Apr 10, 2018 | — |
| S-8 | Employee stock plan registration | Jan 10, 2018 | — |
| S-1 | Registration statement | Oct 9, 2015 | — |
| S-8 | Employee stock plan registration | Feb 5, 2015 | — |
| 424B3 | Prospectus | May 9, 2014 | — |
| S-8 | Employee stock plan registration | May 5, 2014 | — |
| 424B3 | Prospectus | Feb 14, 2014 | — |
| 424B3 | Prospectus | Feb 14, 2014 | — |
| 424B4 | Prospectus | Dec 12, 2013 | — |
| S-1MEF | Filing | Dec 12, 2013 | — |
| S-1/A | Amended registration statement | Dec 11, 2013 | — |
| S-1/A | Amended registration statement | Dec 6, 2013 | — |
| S-1/A | Amended registration statement | Nov 27, 2013 | — |
| S-1 | Registration statement | Oct 17, 2013 | — |
| 424B4 | Prospectus | Oct 1, 2013 | — |
| S-1/A | Amended registration statement | Sep 27, 2013 | — |
| S-1/A | Amended registration statement | Sep 25, 2013 | — |
| S-1/A | Amended registration statement | Sep 20, 2013 | — |
| S-1 | Registration statement | Jul 17, 2013 | — |
| 424B5 | Prospectus supplement | May 9, 2013 | — |
| S-8 | Employee stock plan registration | Mar 8, 2013 | — |
| 424B5 | Prospectus supplement | Jan 7, 2013 | — |
| 424B5 | Prospectus supplement | Mar 2, 2012 | — |
| 424B5 | Prospectus supplement | Jan 9, 2012 | — |
| FWP | Free writing prospectus | Jan 9, 2012 | — |
| S-8 | Employee stock plan registration | Jan 4, 2012 | — |
| S-8 | Employee stock plan registration | Oct 28, 2011 | — |
| 424B5 | Prospectus supplement | Dec 22, 2010 | — |
| S-3 | Shelf registration | Oct 26, 2010 | — |
| 424B3 | Prospectus | Jun 24, 2010 | — |
| S-3/A | Filing | Jun 17, 2010 | — |
| S-8 | Employee stock plan registration | Jun 8, 2010 | — |
| S-3 | Shelf registration | Apr 23, 2010 | — |
| S-8 | Employee stock plan registration | Feb 19, 2009 | — |
Showing 60 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ELOX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Arlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1035354
- Former names
- Sevion Therapeutics, Inc. (until Dec 22, 2017); SENESCO TECHNOLOGIES INC (until Sep 29, 2014); NAVA LEISURE USA INC (until May 24, 1999)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.